Ann: Appendix 3Y x 2, page-11

First 11 Last

Share
Profile

Follow
ateam

223 Posts.

18/10/17

10:52

Post #: 27991761
Share

Originally posted by ecneitap ↑

It's about accountability and Directors across all companies need to be held accountable, especially as most are out to look after themselves not shareholders even though their rhetoric will always state otherwise and they will always say what they know shareholders want to hear. Whether they deserve what they have issued themselves now and in the past is subjective. You think they deserve this amount , I think they need to meet many more milestones before they start issuing themselves with so many shares. Plus as I said I would like more transparency on what KPI's were achieved as well. I think they are also working towards another capital raising which means some further dilution, be it hopefully only minor. Have to remember as well that issuing themselves shares is also dilution.

From a technical perspective the stock is getting close to breaking out (above 10c) and will run to 13.5 - 14c initially on the breakout. Yes that's a good thing for the few that bought in below 10c yet many are still sitting on investments bought between 11c and 20c. Price action is telling us something is going on behind the scenes here so I'm expecting an announcement soon, yet it is interesting that SMURF and the boys have set themselves up with their shares just before we get the anticipated breakout / announcement. They are insiders so they know exactly what is going on, I have to read the charts and price patterns to try and work it out. E.

Expand

I don't see anyone unloading there stock in the directors nor do i in the future ???

this is no KBL mate

if you don't have faith why would you buy ?

and can you tell me how you do your charts when there is a bot on the stock holding it down?

SOR Price at posting: 8.9¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

OJC

SPC to merge with Original Juice Co and Nature One Dairy

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 9 more messages in this thread...

First 11 Last

Add SOR (ASX) to my watchlist

(20min delay)
Last 3.8¢		Change -0.001(2.56%)		Mkt cap ! $17.81M

Open	High	Low	Value	Volume
3.9¢	3.9¢	3.8¢	$2.643K	69.08K

Buyers (Bids)

No.	Vol.	Price($)
3	494115	3.7¢

Sellers (Offers)

Price($)	Vol.	No.
4.0¢	4066	2

View Market Depth

No.	Vol.	Price($)
3	494115	0.037
3	578249	0.036
3	582230	0.035
1	280000	0.034
3	91001	0.033

Price($)	Vol.	No.
0.040	4066	2
0.041	12000	1
0.042	851122	1
0.043	12693	1
0.044	103044	2

Last trade - 11.07am 02/10/2024 (20 minute delay)

SOR (ASX) Chart

Ann: Appendix 3Y x 2, page-11

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SPC to merge with Original Juice Co and Nature One Dairy

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Appendix 3Y x 2, page-11

Top Stories

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SPC to merge with Original Juice Co and Nature One Dairy

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News